Research opportunities related to establishing standards for tobacco products under the family smoking prevention and tobacco control act

Nicotine and Tobacco Research

Volumn 14, Issue 1, 2012, Pages 18-28

  Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; ALDEHYDE; AROMATIC AMINE; BENZENE; CARCINOGEN; CHRYSENE; CIGARETTE SMOKE; COTININE; ETHYLBENZENE; ISOPRENE; NAPHTHALENE; NICOTINE; NITROSAMINE; PHENOL DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; STYRENE; TOXIC SUBSTANCE;

CIGARETTE SMOKING; HUMAN; LAW; MAXIMUM ALLOWABLE CONCENTRATION; MEDICAL RESEARCH; NICOTINE REPLACEMENT THERAPY; NOTE; PRIORITY JOURNAL; STANDARDIZATION; TOBACCO;

EID: 84855176059     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntq216     Document Type: Note

References (50)

1. Baker, R. R. (2006). The generation of formaldehyde in cigarettes-Overview and recent experiments. Food and Chemical Toxicology, 44, 1799-1822. doi:10.1016/j.fct.2006.05.017
2. Baker, R. R., Massey, E. D., & Smith, G. (2004). An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food and Chemical Toxicology, 42(Suppl.), S53-S83. doi:10.1016/j.fct.2004.01.001
3. Baker, R. R., Pereira da Silva, J. R., Jr., & Smith, G. (2004a). The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives. Food and Chemical Toxicology, 42(Suppl.), S3-S37. doi:10.1016/S0278-6915(03)00189-3
4. Baker, R. R., Pereira da Silva, J. R., & Smith, G. (2004b). The effect of tobacco ingredients on smoke chemistry. Part II: Casing ingredients. Food and Chemical Toxicology, 42(Suppl.), S39-S52. doi:10.1016/j.fct.2003.08.009
5. Belluzzi, J. D., Wang, R., & Leslie, F. M. (2005). Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology, 30, 705-712. doi:10.1038/sj.npp.1300586
6. Benowitz, N. L., Hall, S. M., Stewart, S., Wilson, M., Dempsey, D., & Jacob, P., III. (2007). Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiology Biomarkers & Prevention, 16, 2479-2485. doi:10.1158/1055-9965.EPI-07-0393
7. Benowitz, N. L., & Henningfield, J. E. (1994). Establishing a nicotine threshold for addiction. New England Journal of Medicine, 331, 123-125. doi:10.1056/NEJM199407143310212
8. Boffetta, P., Clark, S., Shen, M., Gislefoss, R., Peto, R., & Andersen, A. (2006). Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiology Biomarkers & Prevention, 15, 1184-1188. doi:10.1158/1055-9965.EPI-06-0032
9. Burns, D. M., Dybing, E., Gray, N., Hecht, S., Anderson, C., Sanner, T., et al. (2008). Mandated lowering of toxicants in cigarette smoke: A description of the World Health Organization TobReg proposal. Tobacco Control, 17, 132-141. doi:10.1136/tc.2007.024158
10. Chen, C., & Pankow, J. F. (2009). Gas/particle partitioning of two acid-base active compounds in mainstream tobacco smoke: Nicotine and ammonia. Journal of Agricultural and Food Chemistry, 57, 2678-2690. doi:10.1021/jf803018x
11. Chen, P. X., & Moldoveanu, S. C. (2003). Mainstream smoke chemical analyses for 2R4F Kentucky reference cigarette. Beiträge zur Tabakforschung International, 20, 448-458. Retrieved from http://www.beitraege-bti.de/
12. Church, T. R., Anderson, K. E., Caporaso, N. E., Geisser, M. S., Le, C., Zhang, Y., et al. (2009). A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiology Biomarkers & Prevention, 18, 260-266. doi:10.1158/1055-9965.EPI-08-0718
13. Clemens, K. J., Caille, S., Stinus, L., & Cador, M. (2009). The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. International Journal of Neuropsychopharmacology, 12, 1355-1366. doi:10.1017/S1461145709000273
14. Counts, M. E., Hsu, F. S., Laffoon, S. W., Dwyer, R. W., & Cox, R. H. (2004). Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regulatory Toxicology and Pharmacology, 39, 111-134. doi:10.1016/j.yrtph.2003.12.005
15. Ding, Y. S., Ashley, D. L., & Watson, C. H. (2007). Determination of 10 carcinogenic polycyclic aromatic hydrocarbons in mainstream cigarette smoke. Journal of Agricultural and Food Chemistry, 55, 5966-5973. doi:10.1021/jf070649o
16. Ding, Y. S., Trommel, J. S., Yan, X. J., Ashley, D., & Watson, C. H. (2005). Determination of 14 polycyclic aromatic hydrocarbons in mainstream smoke from domestic cigarettes. Environmental Science and Technology, 39, 471-478. doi:10.1021/es048690k
17. Ding, Y. S., Yan, X. J., Jain, R. B., Lopp, E., Tavakoli, A., Polzin, G. M., et al. (2006). Determination of 14 polycyclic aromatic hydrocarbons in mainstream smoke from U.S. brand and non-U.S. brand cigarettes. Environmental Science and Technology, 40, 1133-1138. doi:10.1021/es0517320
18. Gray, N., Henningfield, J. E., Benowitz, N. L., Connolly, G. N., Dresler, C., Fagerstrom, K., et al. (2005). Toward a comprehensive long term nicotine policy. Tobacco Control, 14, 161-165. doi:10.1136/tc.2004.010272
19. Gregg, E., Hill, C., Hollywood, M., Kearney, M., McAdam, K., McLaughlin, D., et al. (2004). The UK smoke constituents testing study. Summary of results and comparison with other studies. Beiträge zur Tabakforschung International, 21, 117-138. Retrieved from http://www.beitraege-bti.de/
20. Hammond, D., & O'Connor, R. J. (2008). Constituents in tobacco and smoke emissions from Canadian cigarettes. Tobacco Control, 17(Suppl. 1), i24-i31. doi:10.1136/tc.2008.024778
21. Hatsukami, D. K., Benowitz, N. L., Rennard, S. I., Oncken, C., & Hecht, S. S. (2006a). Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine & Tobacco Research, 8, 169-191. doi:10.1080/14622200600576628
22. Hatsukami, D. K., Benowitz, N. L., Rennard, S. I., Oncken, C., & Hecht, S. S. (2006b). Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine & Tobacco Research, 8, 600-622. doi:10.1080/14622200600858166
23. Hatsukami, D. K., Hanson, K., Briggs, A., Parascandola, M., Genkinger, J. M., O'Connor, R., et al. (2009). Clinical trials methods for evaluation of potential reduced exposure products. Cancer Epidemiology Biomarkers & Prevention, 18, 3143-3195. doi:10.1158/1055-9965.EPI-09-0654
24. Hatsukami, D. K., Kotlyar, M., Hertsgaard, L. A., Zhang, Y., Carmella, S. G., Jensen, J. A., et al. (2010). Reduced nicotine content cigarettes: Effects on toxicant exposure, dependence and cessation. Addiction, 105, 343-355. doi:10.1111/j.1360-0443.2009.02780.x
25. Hecht, S. S., Yuan, J.-M, & Hatsukami, D. K. (2010). Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chemical Research in Toxicology, 23, 1001-1008. doi:10.1021/tx100056m
26. Henningfield, J. E., Benowitz, N. L., Slade, J., Houston, T. P., Davis, R. M., & Deitchman, S. D. (1998). Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association. Tobacco Control, 7, 281-293. doi:10.1136/tc.7.3.281
27. Henningfield, J. E., & Zeller, M. (2009). Nicotine psychopharmacology: Policy and regulatory. Handbook of Experimental Pharmacology, 192, 511-534. doi:10.1007/978-3-540-69248-5_18
28. Hoffmann, D., Hoffmann, I., & El Bayoumy, K. (2001). The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chemical Research in Toxicology, 14, 767-790. doi:10.1021/tx000260u
29. Hukkanen, J., Jacob, P., III, & Benowitz, N. L. (2005). Metabolism and disposition kinetics of nicotine. Pharmacological Reviews, 57, 79-115. doi:10.1124/pr.57.1.3
30. International Agency for Research on Cancer. (1986). Tobacco smoking. In IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 38 (pp. 37-385). Lyon, France:. Retrieved from http://www.iarc.fr/en/publications/list/
31. International Agency for Research on Cancer. (2004). Tobacco smoke and involuntary smoking. In IARC monographs on the evaluation of carcinogenic risks to humans, vol. 83 (pp. 53-119). Lyon, France: Author. Retrieved from http://www.iarc.fr/en/publications/list/
32. Intorp, M., Purkis, S., Whittaker, M., & Wright, W. (2009). Determination of "Hoffmann analytes" in cigarette mainstream smoke. The Coresta 2006 Joint Experiment. Beiträge zur Tabakforschung International, 23, 161-202. Retrieved from http://www.beitraege-bti.de/
33. O'Connor, R. J., Cummings, K. M., Rees, V. W., Connolly, G. N., Norton, K. J., Sweanor, D., et al. (2009). Surveillance methods for identifying, characterizing, and monitoring tobacco products: Potential reduced exposure products as an example. Cancer Epidemiology Biomarkers & Prevention, 18, 3334-3348. doi:10.1158/1055-9965.EPI-09-0429
34. Prokopczyk, B., Hoffmann, D., Cox, J. E., Djordjevic, M. V., & Brunnemann, K. D. (1992). Supercritical fluid extraction in the determination of tobacco-specific N-nitrosamines in smokeless tobacco. Chemical Research in Toxicology, 5, 336-340. doi:10.1021/tx00027a003
35. Rodgman, A., & Green, C. R. (2003). Toxic chemicals in cigarette mainstream smoke-Hazard and hoopla. Beiträge zur Tabakforschung International, 20, 481-545. Retrieved from http://www.beitraege-bti.de/
36. Rodgman, A., & Perfetti, T. (2009). The Chemical components of tobacco and tobacco smoke (pp. 1483-1784), Boca Raton, FL: CRC Press. doi:10.1201/9781420078848
37. Roemer, E., Stabbert, R., Rustemeier, K., Veltel, D. J., Meisgen, T. J., Reininghaus, W., et al. (2004). Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology, 195, 31-52. doi:10.1016/j.tox.2003.08.006
38. Schuller, H. M. (2009). Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nature Reviews Cancer, 9, 195-205. doi:10.1038/nrc2590
39. Schwartz, L., Guais, A., Chaumet-Riffaud, P., Grevillot, G., Sasco, A. J., Molina, T. J., et al. (2010). Carbon dioxide is largely responsible for the acute inflammatory effects of tobacco smoke. Inhalation Toxicology, 22, 543-551. doi:10.3109/08958370903555909
40. Seidel, A., Frank, H., Behnke, A., Schneider, D., & Jacob, J. (2004). Determination of dibenzo[a, l]pyrene and other fjord-region PAH isomers with MW 302 in environmental samples. Polycyclic Aromatic Compounds, 24, 759-771. doi:10.1080/10406630490472527
41. Shimada, T., Murayama, N., Okada, K., Funae, Y., Yamazaki, H., & Guengerich, F. P. (2007). Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors. Chemical Research in Toxicology, 20, 489-496. doi:10.1021/tx600299p
42. Smith, C. J., Livingston, S. D., & Doolittle, D. J. (1997). An international literature survey of "IARC Group I Carcinogens" reported in mainstream cigarette smoke. Food and Chemical Toxicology, 35, 1107-1130. doi:10.1016/S0278-6915(97)00063-X
43. Smith, C. J., Perfetti, T. R., Rumple, M. A., Rodgman, A., & Doolittle, D. J. (2000). "IARC Group 2A carcinogens" reported in cigarette mainstream smoke. Food and Chemical Toxicology, 38, 371-383. doi:10.1016/S0278-6915(99)00156-8
44. Smith, C. J., Perfetti, T. A., Rumple, M. A., Rodgman, A., & Doolittle, D. J. (2001). 'IARC Group 2B carcinogens' reported in cigarette mainstream smoke (Vol. 38, pp. 825, 2000). Food and Chemical Toxicology, 39, 181-205. doi:10.1016/S0278-6915(01)00008-4
45. Stepanov, I., Carmella, S. G., Briggs, A., Hertsgaard, L., Lindgren, B., Hatsukami, D. K., et al. (2009). Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Research, 69, 8236-8240. doi:10.1158/0008-5472.CAN-09-1084
46. Stepanov, I., Carmella, S. G., Han, S., Pinto, A., Strasser, A. A., Lerman, C., et al. (2009). Evidence for endogenous formation of N'-nitrosonornicotine in some long term nicotine patch users. Nicotine & Tobacco Research, 11, 99-105. doi:10.1093/ntr/ntn004
47. Stepanov, I., Jensen, J., Hatsukami, D., & Hecht, S. S. (2008). New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels. Nicotine & Tobacco Research, 10, 1773-1782. doi:10.1080/14622200802443544
48. U.S. General Accounting Office. (2003). Pesticides on tobacco: Federal activities to assess risk and monitor residues, GAO-03-485. Retrieved from http://www.gao.gov/products/GAO-03-485
49. Wang, M., Cheng, G., Balbo, S., Carmella, S. G., Villalta, P. W., & Hecht, S. S. (2009). Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and non-smokers. Cancer Research, 69, 7170-7174. doi:10.1158/0008-5472.CAN-09-1571
50. Yuan, J. M., Koh, W. P., Murphy, S. E., Fan, Y., Wang, R., Carmella, S. G., et al. (2009). Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Research, 69, 2990-2995. doi:10.1158/0008-5472.CAN-08-4330